Auftragnehmer

S.C. ROMFARMACHIM S.A.

Bucuresti · ROU

Diesen Eintrag verfolgenKostenloses Konto — Benachrichtigung, sobald hier ein Vertrag ausläuft.

Zuschläge

26

Vergebenes Volumen

15 gemeinsame Vergabe(n) anteilig gerechnet

Auftraggeber

3

Branchen

1

Reg. 14927997

Auslaufende Verträge dieses Auftragnehmers

Alle auslaufenden Verträge

Zuschläge

ZuschlagAuftraggeberAuftragnehmerAuftragswertVeröffentlicht
doxiciclina 100mgSpitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"DR.MAX, S.C. ROMFARMACHIM S.A.8.380 RON17. Sept. 2026
ACETAZOLAMIDUM / ACETAZOLAMIDA / COMPR 250MGUM 0929 BucurestiS.C. ROMFARMACHIM S.A.15.990 RON14. Sept. 2026
DIOSMINUM / DETRALEX 500 / CP FILM 500 MGUM 0929 BucurestiALLIANCE HEALTHCARE ROMANIA, S.C. ROMFARMACHIM S.A.528.000 RON14. Sept. 2026
TIANEPTINUM / COAXIL / DRAJ 12.5 MGUM 0929 BucurestiBYA SELL, FARMEXIM S.A., S.C. ROMFARMACHIM S.A.240.360 RON14. Sept. 2026
DIOSMINUM / DETRALEX 1000 / CP FILM 1000 GUM 0929 BucurestiALLIANCE HEALTHCARE ROMANIA, DEPOTHEKE DEPOZITUL FARMACIILOR INDEPENDENTE, S.C. ROMFARMACHIM S.A.2.856.000 RON14. Sept. 2026
pancreatină 275 mg / COMPRIMATE GASTROREZ.SPITALUL JUDETEAN DE URGENTA VALCEADR.MAX, ND PHARMA S.R.L., PHARM AHEAD S.R.L. +1 weitere17.940 RON4. Sept. 2026
ACETAZOLAMIDUM 250mg/CPRSPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.6.642 RON4. Sept. 2026
ACIDUM ASCORBICUM 750mg/ 5ml / FIOLASPITALUL JUDETEAN DE URGENTA VALCEAALLIANCE HEALTHCARE ROMANIA, DR.MAX, FITERMAN DISTRIBUTION +2 weitere7.159.678 RON4. Sept. 2026
CEFALEXINUM 500mg CAPSULESPITALUL JUDETEAN DE URGENTA VALCEADR.MAX, SC PHARMA SA, S.C. ROMFARMACHIM S.A.10.152 RON2. Sept. 2026
COMBINATII (carbonat de calciu 489 mg, carbonat de magneziu 11 mg şi trisilicat de magneziu 6 mg.) COMPR. MASTICABILSPITALUL JUDETEAN DE URGENTA VALCEADR.MAX, PHARM AHEAD S.R.L., S.C. ROMFARMACHIM S.A.3.290 RON2. Sept. 2026
ERYTHROMYCINUM 200mg COMPRIMATESPITALUL JUDETEAN DE URGENTA VALCEADR.MAX, PHARM AHEAD S.R.L., SC PHARMA SA +1 weitere17.519 RON2. Sept. 2026
INDOMETACINUM 50 mg/ SUPOZ.SPITALUL JUDETEAN DE URGENTA VALCEADR.MAX, FELSIN FARM S.R.L., PHARM AHEAD S.R.L. +2 weitere147.648 RON2. Sept. 2026
COMBINATII (PERINDOPRILUM + INDAPAMIDUM) 10mg/2.5 mg / CPRSPITALUL JUDETEAN DE URGENTA VALCEAPHARM AHEAD S.R.L., S.C. ROMFARMACHIM S.A.2.159 RON2. Sept. 2026
RILMENIDINUM / 1 mg /CPRSPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.1.897 RON2. Sept. 2026
COMBINATII (PERINDOPRILUM + INDAPAMIDUM + AMLODIPINUM)10mg/2.5 mg/10mg CPRSPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.1.871 RON2. Sept. 2026
Metronidazolum 250 Mg / CprSPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.38.229 RON2. Sept. 2026
GLICLAZIDUM 60 MG/ COMPSPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.1.613 RON2. Sept. 2026
COMBINATII (PERINDOPRILUM + AMLODIPINUM)10mg/5mgSPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.1.466 RONRV2. Sept. 2026
COMBINATII (PERINDOPRILUM + INDAPAMIDUM + AMLODIPINUM)5mg/1.25 mg/10mg CPRSPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.1.650 RON2. Sept. 2026
DOXYCYCLINUM 100mg CAPSULESPITALUL JUDETEAN DE URGENTA VALCEADR.MAX, PHARM AHEAD S.R.L., SC PHARMA SA +1 weitere7.923 RON2. Sept. 2026
COMBINATII (PERINDOPRILUM + INDAPAMIDUM + AMLODIPINUM)5mg/1.25 mg/5mg CPR.SPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.1.645 RON2. Sept. 2026
COMBINATII (PERINDOPRILUM + AMLODIPINUM)10mg/10mg CPRSPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.1.466 RONRV2. Sept. 2026
COMBINATII (PERINDOPRILUM + INDAPAMIDUM + AMLODIPINUM)10mg/2.5 mg/5mg CPRSPITALUL JUDETEAN DE URGENTA VALCEAS.C. ROMFARMACHIM S.A.1.976 RON2. Sept. 2026
COMBINATII (PERINDOPRILUM + INDAPAMIDUM) 5mg/1.25 mg / CPRSPITALUL JUDETEAN DE URGENTA VALCEAPHARM AHEAD S.R.L., S.C. ROMFARMACHIM S.A.1.562 RON2. Sept. 2026
INDAPAMIDUM 1.5mg COMPR. ELIB. PREL. /CPRSPITALUL JUDETEAN DE URGENTA VALCEADR.MAX, EUROPHARM HOLDING S.A., PHARM AHEAD S.R.L. +2 weitere3.697 RON2. Sept. 2026
PERINDOPRILUM 5mg /CPRSPITALUL JUDETEAN DE URGENTA VALCEAEUROPHARM HOLDING S.A., PHARM AHEAD S.R.L., S.C. ROMFARMACHIM S.A.9.468 RON2. Sept. 2026